The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study
Infection Control and Hospital Epidemiology Vol.44 No.7 (2023) , 1199-1203
Suggested Citation
Sathitakorn O., Chansirikarnjana S., Jantarathaneewat K., Weber D.J., Warren D.K., Apisarnthanarak P., Tantiyavarong P., Apisarnthanarak A. The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study. Infection Control and Hospital Epidemiology Vol.44 No.7 (2023) , 1199-1203. 1203. doi:10.1017/ice.2022.201 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/88864
Title
The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study
In this quasi-experimental study, implementing a procalcitonin and Clinical Pulmonary Infection Score (CPIS) successfully reduced inappropriate antibiotic use among severely-to-critically ill COVID-19 patients, multidrug-resistant organisms, and invasive fungal infections during the intervention period in 2 medical centers. However, this strategy did not improve inappropriate antibiotic use among mildly-to-moderately ill COVID-19 patients.
